Fred Cohen

Fred Cohen currently is a Senior Managing Director of Vida Ventures, a venture capital firm that he co-founded in 2017. He is also a Senior Advisor to TPG where he served as a Partner and founder of TPG Biotechnology, a life science focused investment effort from 2001-2016. From 1980 through 2014, Dr. Cohen was at UCSF where he held various responsibilities as a research scientist, an Internist for hospitalized patients, a consulting Endocrinologist, and as the Chief of the Division of Endocrinology and Metabolism. Dr. Cohen received his BS degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his MD from Stanford and his postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF. Dr. Cohen was elected to the National Academy of Medicine in 2004 and the American Academy of Arts and Sciences in 2008. In addition to being an inaugural member of the Carolina Research Ventures Advisory Board, Dr. Cohen serves on the Board of Directors for a variety of publicly traded biotechnology and healthcare organizations.